Minimally invasive surgery (MIS) and stereotactic body radiotherapy (SBRT) are both used to treat stage 1 non-small cell lung cancer (NSCLC). While MIS remains the standard of care for patients with ...

There was some incidence of radiation pneumonitis, but I think those rates were comparable with standard chemoradiation. Unfortunately, there were a couple of grade 5 toxicities, which led to death.

TOPLINE: Patients with stage I non–small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) have a low rate of acute toxicities and 90-day mortality, according to a ...

The following is a summary of “Quantitative analysis of interstitial lung abnormalities on computed tomography to predict symptomatic radiation pneumonitis after lung stereotactic body radiotherapy,” ...

Purpose Stereotactic body radiation therapy (SBRT) is an effective option for patients with both early-stage and oligometastatic non–small-cell lung cancer (NSCLC). However, data from Latin America ...

Overall survival rates at 1 and 2 years were 85.6 and 69.7%, respectively. Fifty-two patients experienced radiation pneumonitis, but only 2 patients were symptomatic and presented grade 2 late ...

Introduction Lung cancer is the leading cause of cancer death in America, with approximately 225,000 new diagnoses and 160,000 deaths in the United States each year (1). Lung stereotactic body ...

The correlation between the distribution of the lung opacities and the calculated radiation fields supported the diagnosis of radiation pneumonitis. However, we estimated that the predictable risk of ...